Biotech: Biologics and cell therapy products

3P Biopharmaceuticals has the GMP (Good Manufacturing Practices) certification issued by the AEMPS for the manufacture and release of biological active substances, the release of biological drugs and the release of sterile products for both human and veterinary use and for the manufacture and release of cell therapy product: human allogeneic adult stem cells extracted from hearth tissue an "in vitro“ expanded.

3PBiopharmaceuticals has been renewed by the French Ministry as a “Credit Impôt Recherche”(CIR) company

3PBiopharmaceuticals has been renewed by the French Ministry as a “Credit Impôt Recherche”(CIR) company

3P has been approved as private research organism by the French Ministry of Higher Education and Research valid for the period 2014-2015-2016 at least (could be renewed afterwards). This certification entitles our French clients to benefit from interesting tax credits for R&D activities outsourced to 3P.

The tax credit covers 30% of all R&D expenses and covers all R&D spending: salaries, social security contributions, amortization and depreciation allowances, operating costs, subcontracting, patents and monitoring.
We offer our clients a dedicated experienced team to develop their R&D activities with a personal support and an integral service with the most confidential agreements.